Model Retirement Creates Reproducibility Risk in Biomedical AI Publications
Nathan Wolfrath, Meghan Conroy, Thomas Kosten, Dave Bell, Bhabishya Neupane, Jonah Kindel, Anjishnu Banerjee, Priya Deshpande, et al.
cs.AI
Quick verdict
Quantifies retirement risk for 42% of biomedical LLM paper-model mentions; timely and useful, but has internal number inconsistencies and no error bars.
Summary
This bibliometric study quantifies how often biomedical papers depend on large language models whose retirement undermines computational reproducibility. The authors searched PubMed (January 2022 through mid-2026) for original research applying a named LLM to a biomedical task, screened 65,955 abstracts with a GPT-4o-based extraction agent (temperature 0), normalized model names, and excluded encoder-only, protein, and generic family-level mentions. After restricting to the 50 most-used models with vendor-documented lifecycles, 8,931 paper-model mentions across 5,242 publications remained. Human review of a 50-paper subset found 96.2% extraction accuracy, with most errors missed mentions rather than hallucinations. Commercial closed-weight models accounted for 77.7% of mentions (OpenAI 65.7%; GPT-4, GPT-4o, and GPT-3.5-turbo led). Overall, 41.6% of mentions involved a model already retired at publication (2.9%) or scheduled to retire within two years; the median publication-to-retirement interval was 538 days. The authors recommend mandatory exact version-string reporting, open-weight models plus archived weights for long-horizon tasks, and structured publisher metadata. Limitations include abstract-only extraction, a very small validation subset (50 papers) with an undefined accuracy metric, purely descriptive statistics with no confidence intervals or sensitivity analyses, several internal numeric inconsistencies (e.g., 61,077 vs 65,955 abstracts; GPT-5 cited in 182 papers in text vs 170 in Table 1), and code available only on request — an ironic gap given the paper's thesis.
Review complete
Assessment at a glance
5
risk flags identified
● high 0
● medium 4
● low 1
5 strengths · 5 weaknesses · 5 author questions
AI text signal = Binoculars zero-shot detector score over 20 sampled passages (Fast-DetectGPT co-reported) — absence does not prove human authorship, and a flag does not imply misconduct.
Levels reflect verification complexity — not a quality score. Evolve never rates your paper.
Key claims under review
- 41.6% of 8,931 LLM paper-model mentions in PubMed biomedical research (2022-2026) involve a model already retired at publication (2.9%) or scheduled to retire within two years of publication.
- Commercial closed-weight models account for 77.7% of mentions, with OpenAI alone at 65.7%, concentrating reproducibility risk in a single vendor's deprecation schedule.
- The median interval from publication to model retirement is 538 days (mean 546), comparable to or shorter than typical peer-review-plus-publication lags.
- Model deprecation should be treated as a core reporting and preservation issue: mandatory exact version strings, open-weight preference with archived weights for long-horizon tasks, and structured publisher metadata fields.
Strengths
Timely corpus-scale quantification of a real problem
First large-scale bibliometric measure of deprecation-driven irreproducibility: 8,931 paper-model mentions across 5,242 publications, with 41.6% already or soon-after retired (730-day window) and a 538-day median publication-to-retirement interval (Abstract, Results).
Transparent exclusion criteria and lifecycle sourcing
Explicit drops of encoder-only (BERT), protein (ESM), and generic family names; lifecycle dates compiled from primary vendor pages (OpenAI/Anthropic deprecation docs, refs 14-15) with a four-state status taxonomy: active/scheduled/retired/open-weight (Methods, Name Normalization and Lifecycle Data).
Validation step with an error typology
Actionable, guideline-linked recommendations
Candid limitations section
Weaknesses
Internal numeric inconsistencies
Token validation with an undefined accuracy metric
Zero uncertainty quantification
Unreported corpus attrition and selection bias
Reproducibility posture contradicts the thesis
Full Review Report
$1.99 · one-timeUnlock the complete preliminary analysis Evolve produced for this paper.
Report preview
Scope & Claims
The paper asks a sharply posed question: how much of the biomedical LLM literature cites models that are already retired or will retire soon after publication? Drawing on PubMed (Jan 2022 to mid-2026), the authors screened 65,955 abstracts with a GPT-4o-based extraction agent, normalized model names, compiled lifecycle data for the 50 most-used models from vendor deprecation pages, and computed per-mention intervals between publication and retirement. Headline claims: 77.7% of 8,931 mentions are commercial closed-weight models (OpenAI 65.7%); 41.6% involve a model already retired at publication (2.9%) or scheduled to retire within 730 days; the median publication-to-retirement interval is 538 days. These claims are plausible, useful, and policy-relevant, and the intervention agenda (mandatory version strings, open-weight preference for long-horizon tasks, structured publisher metadata) follows directly from them, anchored to TRIPOD-LLM and MI-CLEAR-LLM adherence data.
The remaining sections cover Methodology Assessment, Statistical Evidence, Results & Reproducibility, Limitations & Risks, and Verdict & Recommendations.
- All 5 strengths & 5 weaknesses, analyzed in detail
- 5 risk flags with severity, section & reviewer questions
- Methods & statistical evidence assessment
- 5 questions a peer reviewer would ask
- Full six-dimension evaluation report & recommendations
One-time purchase · this paper only
One-time purchase, this paper only. AI-generated preliminary analysis — not peer review.
Frequently asked questions
What share of biomedical AI papers relies on models that are already or soon will be retired?
The study finds that 41.6% of 8,931 paper-model mentions in PubMed biomedical research (2022-2026) involve a model that was already retired when the paper appeared (2.9%) or is scheduled to retire within two years of publication; the median interval from publication to model retirement is 538 days.
Which AI models dominate biomedical research, according to this study?
Commercial closed-weight models account for 77.7% of model mentions. OpenAI models dominate with 65.7% of mentions; the top three are GPT-4 (27.8%), GPT-4o (14.8%), and GPT-3.5-turbo (14.2%) — all commercial API models with formally announced retirement dates.
What fixes do the authors propose for LLM reproducibility in biomedical research?
Three interventions: journals should require exact model version strings (e.g., gpt-4o-2024-08-06 rather than GPT-4o); open-weight models with weights archived in a persistent repository should be preferred for long-horizon tasks such as guideline support; and publishers should add structured fields for model version and query date.
How was this study conducted?
The authors searched PubMed for original research from January 2022 to mid-2026, used a GPT-4o-based extraction agent on about 66,000 abstracts to identify model names, normalized the names, compiled release and retirement dates for the 50 most-used models from vendor documentation, and computed the time between each paper's publication and its model's retirement.
About this review
This is an AI-generated preliminary review by Evolve.Pub, produced from the openly available text of the paper. It is not peer review and does not represent the authors' views. The canonical record of the paper is at the publisher link above.
- Figures 1-3 appear only as legends in the extracted text; the underlying plots could not be visually assessed, so claims about visual trends rest on the in-text tallies alone.
- Minor PDF-extraction artifacts are present (the typo 'hallucnations' in Results and a garbled volume number in reference 22); they do not affect any numbers relied on in this review.
Go deeper on this paper
Wrote a paper? Stress-test it before reviewers do.
Upload your manuscript for the same structured scrutiny — reasoning, statistics, evidence, figures, and reproducibility.
